中粮科技(000930) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was CNY 5,411,119,957.49, representing a 26.22% increase compared to CNY 4,287,062,608.64 in the same period last year[7]. - Net profit attributable to shareholders was CNY 2,376,698.22, a significant decrease of 98.68% from CNY 179,738,947.16 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was CNY -12,671,010.69, down 107.65% from CNY 165,606,253.04 in the previous year[7]. - The company's total revenue for the year-to-date was CNY 14,721,188,587.73, reflecting a slight decrease of 1.18% from CNY 14,896,319,948.47 in the previous year[11]. - Total operating revenue for the period reached CNY 14,721,188,587.73, a decrease of 1.17% compared to CNY 14,896,319,948.47 in the previous period[28]. - Net profit for the period was CNY -345,328,717.95, compared to a net profit of CNY 987,536,654.28 in the previous period[30]. - Basic earnings per share were reported at CNY -0.1818, compared to CNY 0.5196 in the previous period[30]. Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 1,266,726,046.49, a decrease of 22.77% compared to CNY 1,640,249,107.89 last year[11]. - The net cash flow from operating activities was CNY 1,266,726,046.49, a decrease of 22.8% compared to the previous period's CNY 1,640,249,107.89[33]. - Cash inflow from operating activities totaled CNY 18,029,755,562.06, down from CNY 19,695,329,892.23, reflecting a decline of 8.5%[33]. - Cash outflow from operating activities decreased to CNY 16,763,029,515.57 from CNY 18,055,080,784.34, a reduction of 7.1%[33]. - Cash inflow from investing activities was CNY 172,130,941.64, compared to CNY 95,284,720.32 in the previous period, an increase of 80.7%[33]. - The net cash flow from investing activities was CNY -336,908,785.03, slightly worse than the previous period's CNY -326,773,895.24[33]. - Cash inflow from financing activities increased to CNY 6,324,030,563.86 from CNY 4,270,175,921.38, a growth of 48.0%[36]. - The net cash flow from financing activities was CNY -254,477,525.16, an improvement from CNY -1,063,921,214.31 in the previous period[36]. - The ending balance of cash and cash equivalents was CNY 1,623,240,203.67, up from CNY 1,386,760,889.24, reflecting an increase of 17.0%[36]. - The company received CNY 44,100,000.00 from minority shareholders during the period[36]. - The company reported a decrease in tax payments to CNY 330,572,016.28 from CNY 421,469,429.27, a decline of 21.6%[33]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 18,100,294,856.56, a decrease of 3.81% from CNY 18,125,612,523.97 at the end of the previous year[7]. - The total assets amount to CNY 17,435,053,890.46, indicating a decrease from the previous period[22]. - The company's equity attributable to shareholders is CNY 10,702,787,627.03, down from CNY 12,094,927,414.69 in the previous period[22]. - The total liabilities amount to CNY 6,371,735,725.11, with current liabilities at CNY 5,864,520,245.89[22]. - The company reported a decrease in short-term borrowings to CNY 3,840,921,568.65 from CNY 2,874,376,515.71[22]. - The total equity at the end of the reporting period is CNY 11,063,318,165.35[22]. - The company has a capital reserve of CNY 6,134,181,866.07, slightly down from CNY 6,134,567,351.63[22]. Research and Development - The company's R&D expenses increased by 16.50% to CNY 113,048,188.82 compared to CNY 97,035,272.22 in the same period last year[11]. - The company reported a significant increase in research and development expenses, totaling CNY 113,048,188.82, up from CNY 97,035,272.22 in the previous period[28]. Shareholder Information - COFCO Bio-chemical Investment Co., Ltd. holds 47.37% of the total shares, amounting to 883,233,262 shares[15]. - The total number of common shareholders at the end of the reporting period is 121,921[15]. - The total number of preferred shareholders is not applicable for this reporting period[19]. - The company has no known related party relationships among shareholders[18]. Financial Expenses - The company experienced a significant increase in financial expenses, primarily due to an increase in loan scale during the reporting period[11]. - The company recorded a financial expense of CNY 64,460,820.29, compared to a financial income of CNY -8,053,157.05 in the previous period[28]. Other Comprehensive Income - Other comprehensive income after tax was CNY -6,088,195.11, down from CNY 37,309,891.11 in the previous period[30]. Return on Equity - The weighted average return on equity was 0.02%, down from 1.53% in the previous year[7]. Inventory - The company’s inventory decreased to CNY 3,086,256,526.18 from CNY 3,763,200,002.79, a reduction of 18.00%[25]. Cash and Cash Equivalents - Cash and cash equivalents increased to CNY 1,625,340,127.93 from CNY 1,016,637,250.32, representing a growth of 59.93%[25].